These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 19758545)

  • 21. Molecular characterization of strains of respiratory syncytial virus identified in a hematopoietic stem cell transplant outpatient unit over 2 years: community or nosocomial infection?
    Machado AF; Sallum MA; Vilas Boas LS; Tateno AF; Machado CM
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1348-55. PubMed ID: 19041056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The probability of extinction in a bovine respiratory syncytial virus epidemic model.
    Griffiths M; Greenhalgh D
    Math Biosci; 2011 Jun; 231(2):144-58. PubMed ID: 21376734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parameter estimation of some epidemic models. The case of recurrent epidemics caused by respiratory syncytial virus.
    Capistrán MA; Moreles MA; Lara B
    Bull Math Biol; 2009 Nov; 71(8):1890-901. PubMed ID: 19568727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling epidemics caused by respiratory syncytial virus (RSV).
    Weber A; Weber M; Milligan P
    Math Biosci; 2001 Aug; 172(2):95-113. PubMed ID: 11520501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.
    Paes B; Steele S; Janes M; Pinelli J
    Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of RSV: implications for managed care.
    Makari D; Hoopes JM; White N
    Manag Care; 2009 Jan; 18(1 Suppl 2):2-7. PubMed ID: 19230529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RSV: protecting the littlest patients.
    Lauts NM
    RN; 2005 Dec; 68(12):46-51; quiz 52. PubMed ID: 16411554
    [No Abstract]   [Full Text] [Related]  

  • 28. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus.
    Stensballe LG; Ravn H; Kristensen K; Meakins T; Aaby P; Simoes EA
    J Pediatr; 2009 Feb; 154(2):296-8. PubMed ID: 19150677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unusual respiratory syncytial virus nosocomial outbreak in an adult psychiatry ward.
    Huang FL; Chen PY; Shi ZY; Chan CH; Huang SK
    Jpn J Infect Dis; 2009 Jan; 62(1):61-2. PubMed ID: 19168963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.
    Stensballe LG; Ravn H; Kristensen K; Agerskov K; Meakins T; Aaby P; Simões EA
    J Allergy Clin Immunol; 2009 Feb; 123(2):398-403. PubMed ID: 19101023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.
    Kristensen K; Stensballe LG; Bjerre J; Roth D; Fisker N; Kongstad T; Svendsen AL; Nielsen BW
    Arch Dis Child; 2009 Oct; 94(10):785-9. PubMed ID: 19541682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation.
    Sampalis JS; Langley J; Carbonell-Estrany X; Paes B; O'Brien K; Allen U; Mitchell I; Aloy JF; Pedraz C; Michaliszyn AF
    Med Decis Making; 2008; 28(4):471-80. PubMed ID: 18556643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus activity-- United States, July 2007-December 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(50):1355-8. PubMed ID: 19092759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nosocomial RSV infection control and outbreak management.
    Bont L
    Paediatr Respir Rev; 2009 Jun; 10 Suppl 1():16-7. PubMed ID: 19651394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain].
    Figueras-Aloy J; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
    An Pediatr (Barc); 2009 Jul; 71(1):47-53. PubMed ID: 19524492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating epidemiological and genetic data with different sampling intensities into a dynamic model of respiratory syncytial virus transmission.
    Kombe IK; Agoti CN; Munywoki PK; Baguelin M; Nokes DJ; Medley GF
    Sci Rep; 2021 Jan; 11(1):1463. PubMed ID: 33446831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extinction times and phase transitions for spatially structured closed epidemics.
    Swinton J
    Bull Math Biol; 1998 Mar; 60(2):215-30. PubMed ID: 9559576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Special populations.
    Fauroux B
    Paediatr Respir Rev; 2009 Jun; 10 Suppl 1():21-2. PubMed ID: 19651396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host immunity during RSV pathogenesis.
    Bueno SM; González PA; Pacheco R; Leiva ED; Cautivo KM; Tobar HE; Mora JE; Prado CE; Zúñiga JP; Jiménez J; Riedel CA; Kalergis AM
    Int Immunopharmacol; 2008 Oct; 8(10):1320-9. PubMed ID: 18687294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent epidemics in small world networks.
    Verdasca J; Telo da Gama MM; Nunes A; Bernardino NR; Pacheco JM; Gomes MC
    J Theor Biol; 2005 Apr; 233(4):553-61. PubMed ID: 15748915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.